Oragenics Inc. (OGEN) is a publicly traded Healthcare sector company. As of November 12, 2026, OGEN trades at $0.30 with a market cap of $1.54M and a P/E ratio of -0.11. OGEN moved -7.21% today. Year to date, OGEN is -59.03%; over the trailing twelve months it is -69.14%. Its 52-week range spans $0.34 to $9.60. Rallies surfaces OGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks OGEN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $1.54M |
| P/E Ratio | -0.11 |
| EPS | $-4.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.60 |
| 52-Week Low | $0.34 |
| Volume | 7.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.84M |
| Gross Margin | 0.00% |
OGEN analyst coverage data. Average price target: $0.00.